QuantuMDx Group Ltd.

QuantuMDx QuantuMDx Group is a multinational medical device developer headquartered in the United Kingdom, with subsidiary operations in the United States and Singapore. The company’s flagship product will be Q-POC™, a handheld molecular diagnostic device that will provide results in 20 minutes for a few pounds at the patient’s side. Expected for commercialisation in 2016, Q-POC will empower overburdened healthcare systems worldwide with gold standard molecular diagnostics at a fraction of the cost of traditional testing. Q-POC’s superior multiplexing capabilities will bring the power of precision medicine to health professionals globally, enabling immediate detection of antimicrobial resistance and subsequent ‘right first time prescribing’. By geotagging and networking this disease data, QuantuMDx will build a real-time global pathogen monitoring system called the Internet of Life™. QuantuMDx's products in development include: Q-PREP™: 10 minute DNA extraction kit Q-POC™: 20 minute sample to result molecular diagnostic device Q-SEQ™: portable genomic sequencer Assays are in development for companion diagnostics, tumour profiling and multi-drug resistant infectious disease testing (including TB, HIV and STIs). Downloads: Find out more about QuantuMDx's product pipeline Introductory Brochure